Neuroendocrine Tumor Treatment Market Overview 2024: Size, Growth Drivers, and Major Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Neuroendocrine Tumor Treatment Market for the Period 2024 to 2033?
The market size for the treatment of neuroendocrine tumors has seen a swift expansion in the past few years. It is projected to leap from $1.94 billion in 2023 to $2.16 billion in 2024, experiencing a compound annual growth rate (CAGR) of 11.4%. The escalation during the historical period can be credited to advancements in clinical investigations and comprehension, educational awareness, exceptional medical skills, progress in radiation therapy, and bolstered care services.
The market for treating neuroendocrine tumors is projected to witness a significant expansion in the coming years. The market is set to surge to $3.19 billion in 2028, with a compound annual growth rate (CAGR) of 10.3%. This progression for the forecasted period can be associated with the advancements in precision medicine, breakthroughs in immunotherapy, minimally invasive methods, and increasing prevalence rates, along with the rise of telemedicine and remote care. The major trends anticipated for the predicted period include improvements in diagnostic technologies, advancements in peptide receptor radionuclide therapy (prrt), the application of nanotechnology in drug delivery, newer radiopharmaceuticals, and interdisciplinary collaboration.
Claim Your Free Sample of the Global Neuroendocrine Tumor Treatment Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12248&type=smp
What Factors Are Responsible for the Growth of the neuroendocrine tumor treatment Market?
The neuroendocrine tumor treatment market’s expansion is anticipated to be fueled by the increasing incidence of neuroendocrine tumors. Neuroendocrine tumors (NETs) are a rare kind of tumor that originates in neuroendocrine cells. The necessity for neuroendocrine tumor treatment lies in its role in managing the symptoms of neuroendocrine tumors, controlling tumor growth, and employing radiation therapy to destroy tumor cells. For example, the American Society of Clinical Oncology (ASCO), a professional organization based in the US, revealed in March 2023 that over 12,000 Americans are diagnosed with neuroendocrine tumors each year, and there were around 171,000 people living with this diagnosis in 2023. Similarly, according to Cancer Australia, a cancer control agency based in Australia, 5,437 individuals were identified with neuroendocrine tumors in 2022, representing 3.4% of all new cases diagnosed that year in August 2022. Consequently, the increasing rate of neuroendocrine tumors is a major factor propelling the growth of the neuroendocrine tumor treatment market.
Which Segments Are Important for Insight into the Neuroendocrine Tumor Treatment Market?
1) By Product: Somatostatin Analogs (SSAs), Targeted Therapy, Chemotherapy, Others Products
2) By Indication: Lungs, Pancreas, Gastrointestinal, Others Indications
3) By End-Users: Hospitals, Oncology Centers, Other End-Users
What Are the Significant Trends Reshaping the Neuroendocrine Tumor Treatment Sector?
A prominent trend emerging in the neuroendocrine tumor treatment market is the clinical development of drugs for therapy. Major players in this market are crafting novel therapies to maintain their standing. To illustrate, in October 2022, US pharmaceutical company Viewpoint Molecular Targeting, Inc. revealed that their [212Pb] VMT-a-NET development had been granted fast-track designation by the US Food and Drug Administration (FDA). VMT-a-NET is an alpha-particle therapy (TAT), developed to destroy cancer cells selectively expressing somatostatin receptors. This fast-track designation by the FDA aims to speed up the development and review process of [212Pb] VMT-a-NET for treating neuroendocrine tumors (NETs). This status is awarded to drugs that can potentially offer significant advances in treatment safety or efficacy for severe conditions.
Order Now for Fast Delivery of Your Neuroendocrine Tumor Treatment Market Report!
Which Regions Are Essential for the Growth of the Neuroendocrine Tumor Treatment Market?
North America was the largest region in the neuroendocrine tumor treatment market in 2023. The regions covered in the neuroendocrine tumor treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Neuroendocrine Tumor Treatment Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the neuroendocrine tumor treatment market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Neuroendocrine Tumor Treatment Market Include
1. Neuroendocrine Tumor Treatment Market Executive Summary
2. Neuroendocrine Tumor Treatment Market Segments
3. Neuroendocrine Tumor Treatment Market Size And Template Market Growth Rate
4. Key Neuroendocrine Tumor Treatment Market Trends
5. Major Neuroendocrine Tumor Treatment Market Drivers
……
25. Key Mergers And Acquisitions In The Neuroendocrine Tumor Treatment Market
26. Top Neuroendocrine Tumor Treatment Companies
27. Neuroendocrine Tumor Treatment Market Opportunities And Strategies
28. Neuroendocrine Tumor Treatment Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Tumor Ablation Therapy Devices Global Market Report 2024
Cancer Tumor Profiling Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-tumor-profiling-global-market-report
Germ Cell Tumor Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/germ-cell-tumor-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
